Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
26 April 2018

 Description: 2018 Macah new Tags: Paediatrics, mother and child, healthcare, community, research, academic hospital, Free State.   

Rolene Strauss Patron of the MACAH Foundation, Oupa Mohoje,
Cheetahs rugby union player, and Kesa Molotsane
who are both champions of the MACAH Foundation.
Photo: Johan Roux

Description: 2018 new new MACAH Tags: Paediatrics, mother and child, healthcare, community, research, academic hospital, Free State.

From left is: Prof Gert van Zyl, MACAH Foundation’s founding
Director and Chairman; Khumo Selebano,
newly appointed Director; Dr Riana van Zyl founding director,
and Prof Andre Venter, Founding director and Project Leader.
Photo: Johan Roux



The Mother and Child Academic Hospital (Macah) Foundation was launched at the University of the Free State (UFS) on 24 April 2018. The foundation is instrumental in the building of a state-of-the-art academic hospital that will provide antenatal care and comprehensive health services for mothers, infants and children in Central South Africa. The hospital will be developed under a project in a partnership between UFS, Afrisky Holdings, and the Free State Department of Health, and will be located on the university’s Bloemfontein Campus but will be privately owned and operated.  

Prof Francis Petersen, UFS Rector and Vice-Chancellor, said in his opening remarks this high-level partnership was a demonstration of the power of working together to implement innovation and development, promoting research and academic excellence, while serving communities that are most in need. “This project is possibly the first of its kind in South Africa. I am really proud that the UFS can be a part of it,” he said. 

Officials from the Mangaung Metropolitan Municipality;  Deputy Director General of the Free State Department of Health, Mr Sekgothe Polelo; members of the UFS rectorate; senior academics in the Faculty of Health Sciences; Dr Rolene Strauss, former Miss World and patron of the Macah Foundation; as well Kesa Molotsane, athlete and UFS student, who is the new face of the Macah Foundation, as well as Oupa Mohoje, Springbok rugby player and captain of the Toyota Free State Cheetahs, who is also the face Macah Foundation among others, were present at the event. Prof Gert van Zyl, Dean of the Faculty of Health Sciences, said the university had a pivotal role to play in shaping the future of children who are the future generation. “If we fail our children, we fail our future, our culture and our being,” he said.

The Macah Foundation’s “Make the first 1000 Days Count” programme emphasises the importance of childcare in the first 1000 days. By the age of five, almost 90% of a child’s brain will be developed. Therefore, it is vital that this period is well monitored to ensure the child grows to be a vigorous and happy individual. As nurturer, a mother’s health is just as significant from conception to birth and beyond. The R20-million programme is still in its early stages, but has already received great support.

Prof André Venter, one of the founding directors of Macah, and Head of Paediatrics and Child Health at the UFS Faculty of Health Sciences, said the success of the mother and child hospital was like a dream come true. 

“We have been working on this concept for seven years. It is a privilege for me to work with children, but more so when we can combine so many skills and expertise in developing a world-class facility that will help members of our communities to thrive.”

The foundation is growing steadily and its founding directors are calling on corporates, businesses, and individuals to support it through their influence, loyalty and financial means.

To find out more about the foundation and pledge your support, visit www.macahfoundation.org.za or send an email to Tertia de Bruin on debruintr@ufs.ac.za or  foundation@macahfoundation.org.za

News Archive

Researcher part of project aimed at producing third-generation biofuels from microalgae in Germany
2016-05-09

Description: Novagreen bioreactor  Tags: Novagreen bioreactor

Some of the researchers and technicians among the tubes of the Novagreen bioreactor (Prof Grobbelaar on left)

A researcher from the University of the Free State (UFS), Prof Johan Grobbelaar, was invited to join a group of scientists recently at the Institute for Bio- and Geo-Sciences of the Research Centre Jülich, in Germany, where microalgae are used for lipid (oil) production, and then converted to kerosene for the aviation industry.

The project is probably the first of its kind to address bio-fuel production from microalgae on such a large scale.  

“The potential of algae as a fuel source is undisputed, because it was these photoautotrophic micro-organisms that were fixing sunlight energy into lipids for millions of years, generating the petroleum reserves that modern human civilisation uses today.  However, these reserves are finite, so the challenge is marrying biology with technology to produce economically-competitive fuels without harming the environment and compromising our food security.  The fundamental ability that microalgae have to produce energy-rich biomass from CO2, nutrients, and sunlight through photosynthesis for biofuels, is commonly referred to as the Third-Generation Biofuels (3G),” said Prof Grobbelaar.

The key compounds used for bio-diesel and kerosene production are the lipids and, more particularly, the triacylglyserols commonly referred to as TAGs.  These lipids, once extracted, need to be trans-esterified for biodiesel, while a further “cracking” step is required to produce kerosene.  Microalgae can store energy as lipids and/or carbohydrates. However, for biofuels, microalgae with high TAG contents are required.  A number of such algae have been isolated, and lipid contents of up to 60% have been achieved.

According to Prof Grobbelaar, the challenge is large-scale, high-volume production, since it is easy to manipulate growth conditions in the laboratory for experimental purposes.  

The AUFWIND project (AUFWIND, a German term for up-current, or new impetus) in Germany consists of three different commercially-available photobioreactor types, which are being compared for lipid production.

Description: Lipid rich chlorella Tags: Lipid rich chlorella

Manipulated Chlorella with high lipid contents (yellow) in the Novagreen bioreactor

The photobioreactors each occupies 500 m2 of land surface area, are situated next to one another, and can be monitored continuously.  The three systems are from Novagreen, IGV, and Phytolutions.  The Novagreen photobioreactor is housed in a glass house, and consist of interconnected vertical plastic tubes roughly 150 mm in diameter. The Phytolutions system is outdoors, and consists of curtains of vertical plastic tubes with a diameter of about 90 mm.  The most ambitious photobioreactor is from IGV, and consists of horizontally-layered nets housed in a plastic growth hall, where the algae are sprayed over the nets, and allowed to grow while dripping from one net to the next.

Prof Grobbelaar’s main task was to manipulate growth conditions in such a way that the microalgae converted their stored energy into lipids, and to establish protocols to run the various photobioreactors. This was accomplished in just over two months of intensive experimentation, and included modifications to the designs of the photobioreactors, the microalgal strain selection, and the replacement of the nutrient broth with a so-called balanced one.

Prof Grobbelaar has no illusions regarding the economic feasibility of the project.  However, with continued research, optimisation, and utilisation of waste resources, it is highly likely that the first long-haul flights using microalgal-derived kerosene will be possible in the not-too-distant future.

Prof Grobbelaar from the Department of Plant Sciences, although partly retired, still serves on the editorial boards of several journals. He is also involved with the examining of PhDs, many of them from abroad.  In addition, he assisted the Technology Innovation Agency of South Africa in the formulation of an algae-biotechnology and training centre.  “The chances are good that such a centre will be established in Upington, in the Northern Cape,” Prof Grobbelaar said.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept